- Global Pharma News & Resources

Active Pharmaceutical Ingredients (API) Market is projected to accelerate at a CAGR of 6.1% from 2023 to 2032 | insightSLICE

The global Active Pharmaceutical Ingredients (API) Market size was estimated to be US$ 207 billion in 2021 and is expected grow at a CAGR of 6.1% between 2023 to 2032.

Active Pharmaceutical Ingredients (API) Market Report will provide insights into Global Share, Developments, Statistics, and Forecasts, for the year 2022-2032.

This study also takes into account the competitive environment and will give an outline of the top market participants in the Active Pharmaceutical Ingredients (API) Market as well as their plans for the market.

Access the sample report:

Additionally, the report will also include statistics regarding important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.

For instance, according to Novartis AG’s assessment of its market sectors, the firm’s Innovative Medicines division generated the majority of the company’s USD 47,445 million in revenue in 2019.

The key players of the Global Active Pharmaceutical Ingredients (API) Market are:

Aurobindo Pharma, Albemarle Corporation, Bayer AG., Boehringer Ingelheim International GmbH., Cipla Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., and Novartis AG.

Major growth factors for Active Pharmaceuticals Ingredients (API) in the biomedical industry:

The main contributing factors to the growth of the global active pharmaceutical ingredients (API) market are said to be the rising investments in biopharmaceuticals, targeted research and development of enhanced drug formulations, increasing generic drug acceptance, high incidence of chronic disorders, and increasing uptake of fake drugs.

Due to differences in the legal environment, manufacturers are moving the production of pharmaceutical active ingredients to various countries throughout the world, which has had a substantial impact on market growth.

Over the past few years, the usage of counterfeit medications has significantly expanded in low- and middle-income nations, which is expected to have an influence on the market for active pharmaceutical ingredients.

However, because these countries implement strong laws, it is anticipated that the impact of counterfeit pharmaceuticals will be minimal.

Additionally, rising prevalence rates of chronic illnesses like cancer, cardiovascular disease, and infectious diseases are anticipated to support the market for active pharmaceutical ingredients (API) in the coming years.

Read more about the report inclusions:

Statistics and information provided in our report for the active pharmaceutical ingredients (API) market:

With a special focus on every company involved in the global active pharmaceutical ingredients (API) market, this report offers an in-depth analysis of leading companies with a majority share of the global market. This will help our clients to identify the key players that focus on active pharmaceutical ingredients (API) products and sales.

Additionally, the market shares of well-known businesses operating in the API market would be calculated in this report. As an example, from this report, Novartis AG operates two business segments namely Innovative Medicines, and Sandoz.

The Innovative Medicines division contributed US$ 37,714 million in revenue in 2019 and is the one that is involved in the production of active pharmaceutical ingredients globally.

The report on the Active Pharmaceutical Ingredients (API) market will include information on the major companies, their business strategies, product portfolios, recent alliances, SWOT assessments, and the status of ongoing research.

This study will take into account the businesses that are engaged in the manufacture of Active Pharmaceutical Ingredients (API) and their activities. The focus of the area of our research devoted to the company’s product portfolio will include all of the goods produced by its Active Pharmaceutical Ingredients (API) production division.

Similarly, the recent advancements section of this report will focus on the most recent developments in the global Active Pharmaceutical Ingredients (API) Market for the years 2022 to 2032, including growth plans, acquisitions, and mergers in addition to the new products launches and strategic partnerships.

Related reports:

Global Non-Invasive Prenatal Testing Market:

Global Cold Laser Therapy Market:

Global Active Pharmaceutical Ingredients (API) Market Key Segments:

By Type of Synthesis

  • Biotech, by Type
    • Generic APIs
    • Innovative APIs
  • Biotech, by Product
    • Monoclonal Antibodies
    • Hormones
    • Cytokines
    • Recombinant Proteins
    • Therapeutic Enzymes
    • Vaccines
    • Blood Factors
  • Synthetic
    • Generic APIs
    • Innovative APIs

By Type of Manufacturer

  • Captive APIs
  • Merchant APIs

By Ingredients Type

  • Generic APIs
  • Innovative APIs

By Application

  • Cardiovascular Diseases
  • Oncology
  • CNS and Neurology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Others

By Drug Type

  • Prescription
  • OTC

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of Active Pharmaceutical Ingredients (API) Market

Due to rising investments in the discovery and development of new drugs, the participation of leading pharmaceutical manufacturing organizations, and the incidence and growth of chronic and lifestyle diseases, North America accounted for the largest share of the global active pharmaceutical ingredients (API) market in 2019 and is predicted to continue doing so during the projected timeline.

Additionally, rising expenditure in biopharmaceutical development is anticipated to boost the market for active pharmaceutical ingredients in North America in the upcoming years.

As a result of rising investments in expanding pharmaceutical manufacturing and implementing cutting-edge medical technology, the Asia Pacific region is anticipated to be the most attractive market for active pharmaceutical ingredients.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 29-Nov-2022